VANTAGEPOINT INVESTMENT ADVISERS LLCVANTAGEPOINT INVESTMENT ADVISERS LLC

Institutional investor · Portfolio as of Q2 2023

Top Holdings10 positions

Checking export access…
Activity:
TLTTLT
ETF

ISHARES TR

2.4M$247.7M37.5%$91.65-1.54%
5 qtrssince 2022-Q2
Increased
89
IVVIVV
ETF

iShares Trust CORE S&P500 ETF

362,970$161.8M24.5%$371.41+14.94%
13 qtrssince 2020-Q2
Decreased
0
AGGAGG
ETF

ISHARES TR

1.4M$136.7M20.7%$93.25-6.74%
13 qtrssince 2020-Q2
Decreased
0
VEAVEA
ETF

VANGUARD FTSE DEVELOPED MARKETS ETF

879,300$40.6M6.1%$40.66+3.18%
2 qtrssince 2023-Q1
Unchanged
0
VUGVUG
ETF

Vanguard Index Funds MORNINGSTAR GROWTH ETF

135,830$38.4M5.8%$34.90+32.96%
4 qtrssince 2022-Q3
Unchanged
0
IJHIJH
ETF

ISHARES CORE S&P MID-CAP ETF

59,500$15.6M2.4%$46.33+8.20%
3 qtrssince 2022-Q4
Decreased
0
IWFIWF
ETF

iShares Trust RUS 1000 GRW ETF

21,170$5.8M0.9%$209.99+27.52%
4 qtrssince 2022-Q3
Unchanged
0
VTVVTV
ETF

VANGUARD INDEX FDS

36,300$5.2M0.8%$119.29+10.68%
5 qtrssince 2022-Q2
Unchanged
0
IWRIWR
ETF

ISHARES RUSSELL MIDCAP ETF

66,200$4.8M0.7%$64.68+7.99%
3 qtrssince 2022-Q4
Decreased
0
IWDIWD
ETF

ISHARES RUSSELL 1000 VALUE ETF

23,400$3.7M0.6%$135.92+9.64%
5 qtrssince 2022-Q2
Unchanged
0
$660.4M
AUM
10
Positions
Q2 2023
Filing
HI score · 1.0/5
Quarterly 13F Value Change
-8%Q3'22$548.7M+4%Q4'22$573.1M+5%Q1'23$600.2M+10%Q2'23$660.4M
Activity profile
$ moved · Q2'23
New0%Increased72%Decreased28%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.4 years
<1Q0%1-4Q50%1-2Y20%2Y+30%

VANTAGEPOINT INVESTMENT ADVISERS LLC manages $660.4M across 10 positions as of Q2 2023. Top holdings: TLT (37.5%), IVV (24.5%), AGG (20.7%). Fund DNA: Steady Compounder. HoldingsIntel Score: 1/5.0.

Q2 2023 Summary

Increased 1, trimmed 4. Top move: TLT (INCREASED, conviction 89). Portfolio: $660M across 10 positions.

Top holdings by portfolio weight

Total AUM$660M
TLT37.52%
IVV24.50%
AGG20.70%
VEA6.15%
VUG5.82%
IJH2.36%
IWF0.88%
VTV0.78%
IWR0.73%
IWD0.56%

Portfolio allocation by GICS sector

Sectors1
Unknown100.00%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Unknown
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Weak(1.0 / 5.0)
Holdings P&L84
Conviction49
Concentration51
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
4Q
VUGVUGVanguard Index Funds MORNINGSTAR GROWTH ETF
Q3 2025 → Q2 2026+6.8M shares+$581.2M
3Q
AVEMAVEMAVANTIS EMERGING MARKETS EQUITY ETF
Q4 2025 → Q2 2026+126,777 shares+$60.7M
2Q
VWOVWOVanguard International Equity Index Funds FTSE EMR MKT ETF
Q1 2026 → Q2 2026+521,392 shares+$44.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used